Literature DB >> 23631290

Successful treatment of intracardiac and pulmonary thrombi in Behçet's disease with oral anticoagulant and immunosuppressive therapy.

Uğur Canpolat1, Hikmet Yorgun, Ali Akdoğan, Kudret Aytemir.   

Abstract

Behçet's disease is a multisystem chronic inflammatory disease generally presenting as recurrent oral-genital ulcers and uveitis. Vascular involvement is a common presentation. However, cardiac involvement is rare in this disorder. In this case report, we present a large right ventricular thrombus detected both in computed tomography and echocardiography in a 32 year-old male patient with complaints of fever, haemoptysis and weight loss. Intracardiac thrombus showed both clinical and radiological regression with oral anticoagulant and immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23631290     DOI: 10.14712/18059694.2015.44

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  4 in total

1.  Is Immunosuppressive and Thrombolytic Therapy Really Effective in a Patient With Intracardiac Thrombosis and Pulmonary Artery Aneurysm due to Behçet's Disease?

Authors:  Nükhet Aladağ Çiftdemir; Selman Gökalp; Tuba Eren
Journal:  Arch Rheumatol       Date:  2019-05-22       Impact factor: 1.472

Review 2.  Intracardiac thrombus in Behçet's disease: four new cases and a comprehensive literature review.

Authors:  Tolga Aksu; Omac Tufekcioglu
Journal:  Rheumatol Int       Date:  2014-11-09       Impact factor: 2.631

Review 3.  Left ventricular intracardiac thrombus in a patient with Behçet disease successfully treated with immunosuppressive agents without anticoagulation: a case report and review of the literature.

Authors:  Tatiana Lisitsyna; Zemfira Alekberova; Pavel Ovcharov; Alexander Volkov; Julia Korsakova; Evgeni Nasonov
Journal:  Rheumatol Int       Date:  2015-06-09       Impact factor: 2.631

Review 4.  Cardiac findings in patients with Behçet's disease: Facts and controversies.

Authors:  Heba Farouk; Hania Salah Zayed; Karim El-Chilali
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.